Staurosporine-Red
Stauroporine-Red is used in HTRF Kinase Binding assays.
-->
Sunitinib-Red is a derivative of Sunitinib, and has been validated as a fluorescent tracer for HTRF Kinase Binding assays.
This compound is derived from Sunitinib, which is a well known inhibitor of the PDGF and VEGF RTK families. Sunitinib, which is an ATP-competitive Kinase inhibitor, is used as a drug to treat renal cell carcinoma and imatinib-resistant gastrointestinal stromal tumors. It has been shown to bind with an affinity of <100 nM to about 18% of the Kinases (both RTK and Ser/Thr). It is therefore useful to address multiple Kinases in the HTRF Kinase Binding assay platform.. The ‘d2’ fluorescent dye used absorbs with its maximum near 650 nm and fluoresces near 670 nm. It is used as an acceptor molecule in HTRF assays.
Sunitinib-Red is supplied as a 25 µM solution in DMSO.
The binding of Sunitinib-Red is detected in a sandwich assay format using the Anti Tag labeled with Europium Cryptate (donor), which binds to the tagged Kinase, and a red fluorescent tracer labelled with d2 (acceptor).
The detection principle is based on HTRF® technology. The HTRF ratio (665/620) will increase upon the addition of more of the tracer, and will saturate depending on the dissociation constant (Kd) of the tracer to the tagged kinase.
To know whether Sunitinib-Red is the tracer best suited to your tagged kinase of interest, we advise you to try the Kinase Binding Discovery kits.
Saturation binding experiments of Sunitinib-Red can be run in 96- or 384-well plates (20 µL final volume).
First, a dilution series ranging between 0 and 1 µM of Sunitinib-Red in the Kinase Binding Buffer is prepared in a 96-well non-binding plate. Next, 5 µL of Kinase Binding Buffer are dispensed into the final 96- or 384-well plate. Then 5 µL of tagged-Kinase are added, followed by 5 µL of Anti-tag Eu-cryptate. Finally, 5 µL of the red tracer solution are added.
The HTRF ratio is measured after 1H of incubation.
The binding of Sunitinib-Red is detected in a sandwich assay format using a specific Anti-GST, 6HIS antibody or Streptavidin labeled with Europium Cryptate (donor), which binds to the tagged Kinase, and a red fluorescent Sunitinib labelled with d2 (acceptor).
The detection principle is based on HTRF® technology. The HTRF ratio (665/620) will increase upon the addition of more Sunitinib-Red, and will saturate depending on the dissociation constant (Kd ) of Sunitinib-Red to the tagged kinase.
When an inhibitor of the kinase is added, Sunitinib-Red will be displaced and the HTRF signal will disappear, depending on the dose.
Pharmacological evaluation of inhibitors of interest can be run in 96- or 384-well plates.
First, a dilution series of inhibitor ranging between 40 µM and 0.23 nM is prepared, and 5 µL of each concentration are dispensed into the plate. Next, 5 µL of tagged-Kinase are added, followed by 5 µL of anti-tag Eu-cryptate. Finally, 5 µL of Sunitinib-Red solution are added, prepared at 4x the final concentration. The HTRF ratio is measured after 1 H of incubation.
Analyses of the data give typical dose response curves ranging between 10 µM and 56 pM, enabling an evaluation of the IC50/Ki values for the inhibitor of interest.
Before perfoming competitive binding studies of inhibitors, the dissociation constant (Kd) of Sunitinib-Red has to be determined on the tagged Kinase of interest. This can be done with the help of the Kinase-GST/6HIS/biotin Discovery kits. A typical saturation binding experiment is performed using tracer concentrations between 0 and 250 nM, and measuring total- and non-specific binding signals. Subtracting the non-specific from the total binding signal gives the specific signal, which can be analysed to give the Kd. Here an example is shown for the determination of the Kd (56 nM) of Sunitinib-Red on 5 nM PDGFRb-GST.
Dose response curves of various known kinase inhibitors (Staurosporine, Dasatinib, Imatinib, Tozasertib, Sunitinib, and Gefitinib) were measured using Sunitinib-Red at its Kd (56 nM) on 5 nM PDGFRb-GST. Staurosporine, Dasatinib, Sunitinib, and Imatinib show show high potencies in good correlation with literature values.
3 app notes on kinase inhibitor selection for kinase binding assays
Determine the best tracer to your kinase binding assay - Application Notes
The ultimate guide to successful kinase binding experiments
Tips for getting the best performance from your Kinase binding assay - Guides
All your HTRF assays in one document! - Catalog
A guide to Homogeneous Time Resolved Fluorescence
General principles of HTRF - Guides
Product Insert Sunitinib-red / 62KB03REDC-62KB03REDE
62KB03REDC-62KB03REDE - Product Insert
The essential white paper to expand your knowledge on kinases
Learn about cutting edge kinase research in this free white paper - Guides
How HTRF compares to Western Blot and ELISA
Get the brochure about technology comparison. - Brochures
How to run a Kinase Binding Platform assay
What to expect at the bench - Videos
Revolutionize your kinases investigations with HTRF
Watch this video to learn more about kinases investigations - Videos
Easy method for kinetic binding determination
How to revolutionize your kinetic binding demonstration with HTRF kinase binding platform assays - Application Notes
Safety Data Sheet (DEU) Sunitinib-red / 62KB03REDC
62KB03REDC - Safety Data Sheet
Safety Data Sheet (ELL) Sunitinib-red / 62KB03REDC
62KB03REDC - Safety Data Sheet
Safety Data Sheet (FRA-FR) Sunitinib-red / 62KB03REDC
62KB03REDC - Safety Data Sheet
Safety Data Sheet (ITA) Sunitinib-red / 62KB03REDC
62KB03REDC - Safety Data Sheet
Safety Data Sheet (SPA) Sunitinib-red / 62KB03REDC
62KB03REDC - Safety Data Sheet
Safety Data Sheet (ENG-GB) Sunitinib-red / 62KB03REDC
62KB03REDC - Safety Data Sheet
Safety Data Sheet (ENG-US) Sunitinib-red / 62KB03REDC
62KB03REDC - Safety Data Sheet
Batch Information Sunitinib-red / 20230219
62KB03REDC Batch 02A - Batch Information
Batch Information Sunitinib-red / 20230928
62KB03REDC Batch 04A - Batch Information
Batch Information Sunitinib-red / 20250418
62KB03REDC Batch 05A - Batch Information
Safety Data Sheet (DEU) Sunitinib-red / 62KB03REDE
62KB03REDE - Safety Data Sheet
Safety Data Sheet (ELL) Sunitinib-red / 62KB03REDE
62KB03REDE - Safety Data Sheet
Safety Data Sheet (FRA-FR) Sunitinib-red / 62KB03REDE
62KB03REDE - Safety Data Sheet
Safety Data Sheet (ITA) Sunitinib-red / 62KB03REDE
62KB03REDE - Safety Data Sheet
Safety Data Sheet (SPA) Sunitinib-red / 62KB03REDE
62KB03REDE - Safety Data Sheet
Safety Data Sheet (ENG-GB) Sunitinib-red / 62KB03REDE
62KB03REDE - Safety Data Sheet
Safety Data Sheet (ENG-US) Sunitinib-red / 62KB03REDE
62KB03REDE - Safety Data Sheet
Batch Information Sunitinib-red / 20230219
62KB03REDE Batch 02A - Batch Information
Batch Information Sunitinib-red / 20230729
62KB03REDE Batch 03 - Batch Information
Choosing the right microplate reader ensures you’ll get an optimal readout. Discover our high performance reader, or verify if your lab equipment is going to be compatible with this detection technology.
Let's find your readerYou might be interested in